Published in Medical Letter on the CDC and FDA, November 16th, 2003
According to recent research from the United States, "Naltrexone was approved by the U.S. Food and Drug Administration (FDA) in December 1994. Although it is one of only two medications for alcohol rehabilitation approved in the U.S., naltrexone is not frequently prescribed. This paper examines the factors limiting physicians' use of naltrexone."
"Data were collected through a survey of U.S. physician members of two addiction medicine professional associations," stated Tami L. Mark and collaborators at the Medstat Group and the University of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA